Institutional Ownership
Contineum Therapeutics Inc
CUSIP 21217B100CL ACTNMQ1 2026
Institutional Holders
86
13F filers
Shares Held
29.16M
Aggregate institutional
Institutional Value
$379.62M
Q1 2026
Net New Holders
+6
18 new · 12 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions18
Increased29
Decreased20
Sold out12
Institutional Holders
86 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 2.84M | $37.11M | 0 | Held |
| 2 | Janus Henderson Group PLC | 2.73M | $35.59M | +285.9K | Added |
| 3 | Johnson & Johnson | 1.98M | $25.85M | 0 | Held |
| 4 | Franklin Resources Inc | 1.84M | $24.02M | −40.1K | Reduced |
| 5 | Balyasny Asset Management L.P. | 1.69M | $22.01M | −157.2K | Reduced |
| 6 | Millennium Management LLC | 1.54M | $20.05M | +704.8K | Added |
| 7 | Baker Bros. Advisors LP | 1.42M | $18.56M | 0 | Held |
| 8 | Ra Capital Management, L.P. | 1.30M | $16.93M | −883.7K | Reduced |
| 9 | Perceptive Advisors LLC | 1.26M | $16.40M | −209.0K | Reduced |
| 10 | Fmr LLC | 814.9K | $10.64M | 0 | Held |
76 more institutional holders on Premium
See every fund holding Contineum Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders